Prime Medicine Inc.

PRME | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.19

+$0.07 (+2.24%)

At close: Sep 21, 2026, 4:00 PM ET

$3.22

+$0.03 (+0.94%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $563.53M

Enterprise Value $593.58M

Beta 2.35

Average Volume 3.07M

Shares Outstanding (Diluted) 177.22M

Shares Change YoY 37.19%

Institutional Ownership 55.66%

Exchange NASDAQ

ISIN US74168J1016

Price Performance

Price Change 1M -5.3%

Price Change 3M -1.5%

Price Change 6M -12.1%

Price Change YTD -9.6%

Price Change 1Y -36.1%

Price Change 3Y -71.2%

Price Change 5Y -79.8%

1M CAGR (ann.) 5.8%

1Y CAGR (ann.) -32.9%

5Y CAGR (ann.) N/A

All-Time CAGR -33.5%

Valuation

PE Ratio -2.90

Forward PE N/A

PEG Ratio -0.07

Forward PEG 0.59

PS Ratio 141.46

Forward PS 54.60

PB Ratio 14.47

P/FCF Ratio -3.61

P/Adj. FCF Ratio -3.09

P/OCF Ratio -3.62

EV/Sales 145.73

EV/EBIT -3.16

EV/EBITDA -3.29

EV/FCF -3.71

Earnings Yield -34.5%

FCF Yield -27.7%

Adj. FCF Yield -32.4%

Financial Health

Net Debt $17.41M

Total Debt $112.48M

Cash & Short-Term Investments $95.07M

Total Assets $249.04M

Current Ratio 3.05

Quick Ratio 3.05

Debt / Equity Ratio 2.83

Debt / EBITDA -0.62

Debt / FCF -0.70

OCF / Debt -1.41

Interest Coverage 0.00

Altman Z-Score -6.05

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin -1025.6%

Operating Profit Margin -4824.9%

EBITDA Margin -4431.5%

Net Profit Margin -4613.1%

FCF Margin -3923.7%

Adj. FCF Margin -4581.0%

SBC / Revenue 657.3%

SBC Impact (per share) -16.8%

Returns

Return on Assets -75.5%

Return on Equity -188.3%

Return on Invested Capital -86.8%

Return on Capital Employed -90.4%

Return on Tangible Assets -75.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 54.3%

Revenue CAGR 5Y 68.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 32.0%

EPS CAGR 5Y 7.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 14.4%

FCF CAGR 5Y -4.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y 5.8%

Revenue Growth Next 3Y 49.2%

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.23

EPS Growth Est (next Q) -28.1%

Revenue Est (next Q) $1.32M

Revenue Growth Est (next Q) 7.7%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7.50

Price Target Upside 135.1%

Cash Flow

Operating Cash Flow $-159.02M

Free Cash Flow $-159.81M

Adj. Free Cash Flow $-186.59M

FCF Per Share -$0.89

OCF Per Share -$0.88

OCF/S Ratio -3831.4%

Income Statement

Revenue $4.07M

Gross Profit $-41.77M

Operating Income $-196.52M

EBITDA $-180.49M

Net Income $-187.89M

EPS (Diluted) -$1.10

Revenue / Employee $27.9K

Profit / Employee $-1.29M

Employees 146